Tufton Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-40,328	Closed	-$1.34M	–	132
2017 Q2	$1.34M	Buy	40,328 +2,295	+6%	+$71K	0.27%	68
2017 Q1	$1.22M	Buy	38,033 +585	+2%	+$20K	0.24%	69
2016 Q4	$1.36M	Sell	37,448 -2,855	-7%	-$114K	0.28%	67
2016 Q3	$1.85M	Buy	40,303 +320	+0.8%	+$16.7K	0.37%	67
2016 Q2	$2.01M	Sell	39,983 -2,977	-7%	-$158K	0.41%	64
2016 Q1	$2.3M	Sell	42,960 -545	-1%	-$32K	0.57%	57
2015 Q4	$2.86M	Sell	43,505 -2,365	-5%	-$146K	0.7%	55
2015 Q3	$2.59M	Sell	45,870 -1,380	-3%	-$89.5K	0.57%	60
2015 Q2	$2.79M	Sell	47,250 -14,292	-23%	-$882K	0.56%	62
2015 Q1	$3.83M	Sell	61,542 -90	-0.1%	-$5.23K	0.7%	58
2014 Q4	$3.54M	Sell	61,632 -935	-1%	-$52.1K	0.65%	57
2014 Q3	$3.36M	Sell	62,567 -770	-1%	-$40.8K	0.63%	59
2014 Q2	$3.32M	Sell	63,337 -193	-0.3%	-$9.87K	0.67%	60
2014 Q1	$3.36M	Buy	63,530 +50	+0.1%	+$2.31K	0.7%	56
2013 Q4	$2.54M	Buy	+63,480	New	+$2.5M	0.54%	67